Literature DB >> 32276781

Low-cost production of handrubs and face shields in developing countries fighting the COVID19 pandemic.

Surbhi Khurana1, Parul Singh1, Tej Prakash Sinha2, Sanjeev Bhoi2, Purva Mathur3.   

Abstract

Entities:  

Mesh:

Year:  2020        PMID: 32276781      PMCID: PMC7124313          DOI: 10.1016/j.ajic.2020.03.016

Source DB:  PubMed          Journal:  Am J Infect Control        ISSN: 0196-6553            Impact factor:   2.918


× No keyword cloud information.
To the Editor(s): The COVID-19 caused by the novel coronavirus now known as SARS-CoV-2 (severe acute respiratory syndrome coronavirus-2), has spread worldwide with its first reported case in late December 2019 in Wuhan city of China. This rapidly growing pandemic has also affected many healthcare workers. A recent report from China classified an overall 14.8% of confirmed cases among health workers as severe or critical and 5 deaths were observed. Presently, the clinical spectrum of the disease is being defined including the potential for asymptomatic spread. So far, no specific treatment and prevention strategies like targeted antiviral drugs and vaccines are available for COVID-19. Thus, we can only depend on the traditional public health outbreak response practices—isolation, quarantine, social distancing, and community containment. Such times call for judicious and appropriate use of personal protective equipment (PPE)––gloves, masks, face shields, and handrubs among healthcare workers. In populous countries like India, judicious use of PPE can be a game-changer. Thus, the Infection Control Team at the JPNA Trauma Center, AIIMS, New Delhi has the taken measures such as in-house production of the WHO-recommended handrubs on a large scale and indigenous face shields to be used by the healthcare workers in the hospital (Fig 1 ).
Fig 1

(A) Indigenously prepared WHO-recommended alcohol based handrubs. (B) In-house low-cost face shields made in the laboratory using readily available raw materials.

(A) Indigenously prepared WHO-recommended alcohol based handrubs. (B) In-house low-cost face shields made in the laboratory using readily available raw materials. The usefulness of both the in-house developed PPE has been tested by the treating clinicians at the Center. Both the formulations of handrubs––ethanol & isopropyl alcohol, have proved to be effective. The in-house made face shields were prepared using the readily available materials like foam, transparency sheets, and elastic bands. The cost of each face shield was just 15 Indian rupees INR. It took us approximately 2 minutes to make each face shields. The residents wore the face shield for almost 4 hours without discomfort. Such cost-effective measures towards preparedness to battle the pandemic could be taken by all healthcare facilities across the globe, to overcome the expected crises of PPE and halt the outbreak. With the expected shortage of masks, we are also looking at the option to make triple-layered masks using indigenous materials.
  3 in total

1.  Presumed Asymptomatic Carrier Transmission of COVID-19.

Authors:  Yan Bai; Lingsheng Yao; Tao Wei; Fei Tian; Dong-Yan Jin; Lijuan Chen; Meiyun Wang
Journal:  JAMA       Date:  2020-04-14       Impact factor: 56.272

2.  Challenges of coronavirus disease 2019.

Authors: 
Journal:  Lancet Infect Dis       Date:  2020-02-17       Impact factor: 25.071

3.  Characteristics of and Important Lessons From the Coronavirus Disease 2019 (COVID-19) Outbreak in China: Summary of a Report of 72 314 Cases From the Chinese Center for Disease Control and Prevention.

Authors:  Zunyou Wu; Jennifer M McGoogan
Journal:  JAMA       Date:  2020-04-07       Impact factor: 56.272

  3 in total
  2 in total

1.  Disinfection chain: A novel method for cheap reusable and chemical free disinfection of public places from SARS-CoV-2.

Authors:  Sushanta Debnath; Mohiul Islam
Journal:  ISA Trans       Date:  2021-03-29       Impact factor: 5.911

Review 2.  Processing and Quality Control of Masks: A Review.

Authors:  Sedigheh Farzaneh; Mohammadali Shirinbayan
Journal:  Polymers (Basel)       Date:  2022-01-11       Impact factor: 4.329

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.